A study by MSK found that a high-fiber, plant-based diet may delay progression to multiple myeloma in at-risk individuals. Researchers at Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first clinical trial to demonstrate that a high-fiber, plant-based dietary intervention may delay the progression to multiple myeloma—a rare and currently incurable blood cancer that affects the bone marrow. The study involved 20 participants diagnosed with a precancerous blood disorder and an elevated body mass index (BMI), placing them at higher risk for developing multiple myeloma. Over 12 weeks, participants followed a high-fiber, plant-based meal plan and received...